Drug Trial Radar · NCT02271217
A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
Last checked: Nov 20, 2026Latest source record: Jun 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
377
Actual
Start
Dec 2014
Primary completion
Sep 2016
Study completion Oct 2016
Sponsor
- Lead sponsor
- Acorda TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 22, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to determine the effect of two dose strengths of dalfampridine-Extended Release (ER) tablets, taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.
Conditions
- Post-Ischemic Stroke
Interventions
PlaceboDrug
dalfampridine-ER 7.5mgDrug
dalfampridine-ER 10mgDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who Show at Least a 20% Improvement on the Two Minute Walk Test (2MinWT) at Week 12Time frame: Week 12
Locations
74 sites in 2 countries. Site status is shown where the registry gives one.
Acorda Site #117
Gilbert, Arizona
Acorda Site #109
Berkeley, California
Acorda Site #138
Long Beach, California
Acorda Site #105
Newport Beach, California
Acorda Site #170
Oceanside, California
Acorda Site #142
Pasadena, California
Acorda Site #153
Sacramento, California
Acorda Site #151
San Diego, California
Acorda Site #163
San Diego, California
Acorda Site #124
Colorado Springs, Colorado
Acorda Site #110
Danbury, Connecticut
Acorda Site #149
Fairfield, Connecticut
Acorda Site #130
Stamford, Connecticut
Acorda Site #115
Atlantis, Florida
Acorda Site #119
Deerfield Beach, Florida
Acorda Site #147
Gainesville, Florida
Acorda Site #128
Hialeah, Florida
Acorda Site #143
Jacksonville, Florida
Acorda Site #103
Miami, Florida
Acorda Site #133
Miami, Florida
Acorda Site #161
Naples, Florida
Acorda Site #145
Sunrise, Florida
Acorda Site #106
Tampa, Florida
Acorda Site #186
Atlanta, Georgia
Acorda Site #181
Kailua, Hawaii
Acorda Site #171
Chicago, Illinois
Acorda Site #148
Avon, Indiana
Acorda Site #188
Fort Wayne, Indiana
Acorda Site #156
Franklin, Indiana
Acorda Site #146
Lexington, Kentucky
Acorda Site #150
New Orleans, Louisiana
Acorda Site #175
Fulton, Maryland
Acorda Site #136
Boston, Massachusetts
Acorda Site #121
Boston, Massachusetts
Acorda Site #120
Worcester, Massachusetts
Acorda Site #164
Bingham Farms, Michigan
Acorda Site #127
Detroit, Michigan
Acorda Site #123
East Lansing, Michigan
Acorda Site #159
Grand Rapids, Michigan
Acorda Site #101
Kansas City, Missouri
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.